LT Antibacterial Foam with Silver Dressing
Zhejiang Longterm Medical Technology Co., Ltd. · Decision date Sep 10, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 09/10/2026 for K254246, submitted by Zhejiang Longterm Medical Technology Co., Ltd. of Deqing, CN. The device is listed as LT Antibacterial Foam with Silver Dressing, classified under the occlusive wound dressing category (21 CFR 878.4020), product code NAD, with FRO as a subsequent product code. The application was received 12/29/2025 and reviewed by the General & Plastic Surgery panel as a traditional 510(k); the page states it was not reviewed by a third party and was recorded as a combination product.
SESE means the submission was cleared as substantially equivalent to a predicate device; it is not a PMA approval. The public record does not identify the predicate device, the specific silver component or foam construction details, or the basis for the equivalence finding, and no summary statement is included in the supplied data. A predetermined change control plan was not authorized. Whether the silver component raises any separate regulatory consideration is not addressed in the available fields.
Readers should treat this as a dated clearance record only. The page does not provide indications, performance data, or labeling, so no clinical or comparative conclusions can be drawn from it.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 10, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254246
- Regulatory pathway
- 510(k) premarket notification
- Product code
- NAD
- Decision code
- SESE
- Decision date
- Sep 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Dressing, Wound, Occlusive.
- Product code
- NAD
- FDA device class
- 1
FDA decision timeline
K254246 received
Application receipt date recorded by FDA.
K254246 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zhejiang Longterm Medical Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Deqing
Sources and methodology
- Original FDA record: K254246
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records